Search
for
Sort by
Research 121–150 of 1000+
- Immunoglobulin E and Serum Interleukin-13 and Bacteria in Patients with Alopecia Areata
- Effect of diode pumping solid state laser with wavelength 589 nm on gene expression of interlukine-2 and interferon-gamma Lowercase in human T-lymphocytes
- Das weiße Hautfettgewebe initiiert die IL-33-abhängige Expression von Interleukin 4/13 in myeloischen Zellen während einer Entzündung
- Interleukin‐13 as a promising therapeutic target for alopecia areata associated with atopic dermatitis
- Serum Interleukin 17 as a Marker for Alopecia Areata Severity: A Case-Control Study
- Data from Tumor Necrosis Factor-α and Interleukin-1 Antagonists Alleviate Inflammatory Skin Changes Associated with Epidermal Growth Factor Receptor Antibody Therapy in Mice
- Data from Tumor Necrosis Factor-α and Interleukin-1 Antagonists Alleviate Inflammatory Skin Changes Associated with Epidermal Growth Factor Receptor Antibody Therapy in Mice
- Interleukin 15 Gene Polymorphism in patients with Alopecia Areata
- Increased serum interleukin-17A levels correlate with disease severity and poor prognostic factors in patients with alopecia areata
- Serum Level of Interleukin 17 in Alopecia Areata Patients and Its Relation with the Severity of the Disease: a Case Control Study
- 061 Selective inhibition of tyrosine kinase 2 prevents and restores interleukin-12-induced hair follicle immune privilege collapse: a novel approach to alopecia areata therapy?
- Serum Interleukin 19 in Patients with Alopecia Areata
- Interleukin-1 and Keratinocyte Growth Factor/Fibroblast Growth Factor-7 Gene Expression in Skin Experimental Irritant Contact Dermatitis Mouse Model Treated with Aqueous Extract of Trachyspermum copticum (L.) Link Seeds
- Alopesi areata hastalarında serum interferon-gama, tümör nekrozis faktör-alfa, interlökin-13, interlökin-17 ve transforming growth faktör-beta düzeylerinin değerlendirilmesi
- Topische Immuntherapie mit Diphenylcyclopropenon bei verschiedenen Typen der Alpecia areata: Assoziation zu klinischen Parametern und einem funktionellen Genpolymorphismus des Interleukin-6-Promotors
- Regularities of Change Concentrations of Interleukin-17A, Interleukin-2 and Interleukin-10 in the Blood of People with Alopecia Areata before and after Treatment with Platelet-Rich Plasma
- Repigmentation and new growth of hairs after anti–interleukin-17 therapy with secukinumab for psoriasis
- Serum Interleukin 17 in Patients with Pattern Hair Loss
- Detection of Serum Levels of Interleukins-17, 21, 6 and Tumor Necrosis Factor-α in Patients with Patchy Alopecia Areata and Their Association with Disease Severity
- Alopecia Areata: an Update on Etiopathogenesis, Diagnosis, and Management
- Hair follicle–derived IL-7 and IL-15 mediate skin-resident memory T cell homeostasis and lymphoma
- Cutaneous scarring: Pathophysiology, molecular mechanisms, and scar reduction therapeutics
- The Human Sebocyte Culture Model Provides New Insights into Development and Management of Seborrhoea and Acne
- Alopecia areata: a review of disease pathogenesis
- Dihydrotestosterone-Inducible IL-6 Inhibits Elongation of Human Hair Shafts by Suppressing Matrix Cell Proliferation and Promotes Regression of Hair Follicles in Mice
- Characterization of Hair Follicle Antigens Targeted by the Anti-Hair Follicle Immune Response
- Scarless wound healing: finding the right cells and signals
- Tregs: Where We Are and What Comes Next?
- Probiotic Bacteria Induce a ‘Glow of Health’
- Role of Cytotoxic T Cells in Chronic Alopecia Areata